Mia's Feed
Medical News & Research

Uncovering the Hidden History of Fundraising for Hospital Imaging Technology

Uncovering the Hidden History of Fundraising for Hospital Imaging Technology

Share this article

A groundbreaking report uncovers the vital role of fundraising in bringing advanced medical imaging technology to UK hospitals, highlighting decades of community efforts that have shaped modern healthcare.

2 min read

A recent research report titled "Equipping the Future: The Role of Fundraising in Historic Hospital Scanner Appeals" sheds light on the vital role that charitable fundraising has played in the development and deployment of life-saving medical imaging technology. Published by the University of Kent and authored by charity consultant Jayne Lacny in collaboration with Professor Beth Breeze, the report explores how hospitals across the UK relied heavily on donations to acquire early MRI and CT scanners during the 1970s and beyond.

The use of advanced imaging scanners, such as MRI and CT, has become integral to diagnosing and treating a variety of conditions including cancer, blood clots, diabetes, strokes, and internal injuries. In 2023 alone, the UK hospitals performed approximately 7.1 million CT scans and 4.1 million MRI scans, illustrating how commonplace these technologies have become.

Initially, the high costs of scanners meant NHS hospitals turned to fundraising efforts to make these devices accessible to patients. The report's analysis is partly based on newly deposited papers from Craigmyle Fundraising Consultants, housed in the UK Philanthropy Archive at the University of Kent, providing a comprehensive view of fundraising strategies over the past six decades.

Professor Breeze emphasized the importance of preserving this history, stating that understanding the evolution of fundraising efforts amplifies our appreciation of the social history and the community-driven efforts behind medical advancements.

Jayne Lacny highlighted that many hospital scans today are, at least partly, funded through voluntary donations. Furthermore, the Craigmyle papers encompass 60 years of materials on fundraising campaigns across various sectors, offering valuable lessons for contemporary fundraising approaches.

Current Craigmyle Director Siân Newton expressed pride in the historical work encapsulated in the collection, recognizing the leadership of Craigmyle in UK fundraising history. This research underscores how philanthropic endeavors have significantly contributed to healthcare improvements, shaping patient care standards we benefit from today.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Study Finds No Survival Benefit of Concurrent Durvalumab with Chemoradiotherapy in Unresectable Stage III NSCLC

A groundbreaking phase III trial reveals that adding durvalumab concurrently with chemoradiotherapy does not improve overall survival in patients with unresectable stage III NSCLC, reaffirming the current standard of post-CRT consolidation therapy.

Innovative Smartphone Tests May Speed Up Huntington's Disease Drug Development

New smartphone-based digital tests offer a sensitive and convenient way to monitor Huntington's disease progression, potentially accelerating drug development and clinical trials.

Revolutionary Approach Reprograms Stem Cells to Produce Durable Cancer-Fighting T Cells

UCLA researchers have pioneered a method to reprogram blood stem cells to produce a renewable source of cancer-fighting T cells, opening new possibilities in immunotherapy for hard-to-treat cancers.

Diabetes Medication May Reduce Dementia Risk and Lower Mortality

New research indicates that metformin, a common diabetes drug, may lower the risk of dementia and early death, especially among overweight and obese adults. Discover the potential expanded benefits of this medication in recent studies.